Cairo – Mubasher: The board of Memphis Pharmaceutical and Chemical Industries has approved a rise in the issued and paid-up capital to EGP 241.25 million from EGP 56.25 million.

The capital increase includes Holding Co for Pharmaceuticals' 60% stake in settlement on credit balances, according to a bourse filing on Wednesday.

It is noteworthy to mention that in the July-September period, the company registered net losses of EGP 4.41 million, against net profits of EGP 8.03 million in the year-ago period.

Source: Mubasher

All Rights Reserved - Mubasher Info © 2005 - 2022 Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.